SB682: Maryland Medical Assistance Program - Gender-Affirming Treatment (Trans Health Equity Act of 2022)

Legislative Summary

Requiring, beginning on January 1, 2023, the Maryland Medical Assistance Program to provide gender-affirming treatment in a nondiscriminatory manner; requiring that the gender-affirming treatment be assessed according to nondiscriminatory criteria that are consistent with current clinical standards; prohibiting the issuance of an adverse benefit determination related to gender-affirming treatment unless a certain experienced health care provider has reviewed and confirmed the appropriateness of the determination; etc.